Navigation Links
Essilor : First Half 2009 Results
Date:8/26/2009

    An Excellent First Half:

    - Contribution Margin Maintained at a High 18.2%
    - A Further Increase in Basic Earnings per Share
    - Sharp Rise in net Cash Flow


    The Board of Directors of Essilor International, the world leader in
ophthalmic optics, has approved the financial statements for the six months
ended June 30, 2009.

    EUR millions                  First-half 2009 First-half 2008  % Change

    Revenue                          1,663.4         1,520.2         +9.4%
    Contribution margin                302.6           276.3         +9.5%

    % of revenue                        18.2 %          18.2 %          -
    Profit attributable to equity      202.4           198.3         +2.1%
    holders of Essilor
    International
    Basic earnings per share (in        0.98            0.96         +2.4%
    EUR)


    The highlights of the first half were:

    - The successful launch of new products in an overall
      ophthalmic optics market that experienced slower growth. Among the
      products were the Crizal Forte(R) anti-reflective lens, the Essilor
      Transitions(R) variable-tint lens in Europe, the Xperio(TM) polarized
      lens in the United States and the new Mr Blue(TM) edger.
    - Sustained growth momentum in emerging markets, notably India,
      South Korea, China, the ASEAN countries, Latin America, South Africa
      and Russia.
    - Strong operating profitability with a contribution margin (18.2%)
      that returned to its all-time high of first-half 2008 (including
      Satisloh) thanks to cost discipline across the organization.
    - Profit attributable to equity holders of Essilor that remained
      high at 12.2% of revenue and a further increase in earnings per share.
    - An ongoing external growth strategy, with the acquisition of 11
      companies around the world representing approximately EUR47 million in
      full-year revenue.
    - A sharp 12.5% incre
'/>"/>
SOURCE Essilor
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
2. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
3. Essilor Enters Bulgarian Market
4. Essilor : 2007 Results
5. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
6. Essilors 2008 First-Quarter Report
7. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
8. Essilor - First-Half 2008 Revenue
9. Essilor Steps Up its Development in Eastern Europe
10. Essilor Agrees to Acquire Signet Armorlite
11. Essilor : 2008 Revenue

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...nershipswithMinorityBanksin Washington D.C. ,...C. IntendedtoSpurEconomicGrowthandRevitalization .../--DaVita,thenation,sleadingproviderofdialysisserv...nacostiacommunityfora$1millioninvestmentinIndustri...tycommunities. ,, DaVita,sinvestmentinWashingto...
(Date:11/23/2009)...llion Alliance ProgramSupportsFutureLeadersinSTE...ableat www.Allia n ceS c holars.org...--"Mr.President,youcancountusin.Withourcommunity,f...beapartofEducatetoInnovate,"saidAdolphP.Falcon,Sen...alth,afterattendingaWhiteHousemeetingtodaywherePre...
(Date:11/23/2009)...AMPTON,N.Y.,Nov.23/PRNewswire-USNewswire/--Southam...avedonated$5milliontofundanewEmergencyDepartment.T...bletheHospitaltoalmostdoubletheexistingspaceandgre...visitorsoftheSouthForkofLongIsland. ,, Schedule...rgencyDepartment willprovideacentralizedtraumanurs...
(Date:11/23/2009)...olyps can impair breathing, protein may be the cau... -- U.S. researchers say they,ve identified a pro...ent to 30 percent of people with chronic sinusiti...orms of sinusitis, a constant irritation and swell...growths of sinus tissue -- can block the sinus pas...
(Date:11/23/2009)...of Alberta graduate student Jennifer Heys wants to...ucation in Ugandan communities about contraception... and their desire to bear more children, was read ...st week at the International Conference on Family ... at the School of Public Health, spent six months ...
Breaking Medicine News(10 mins):Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Southampton Hospital Receives $5 Million Gift for New Emergency Department 2Health News:Research Yields Clues to Severe Form of Sinusitis 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2
...ing at the 2009,South Beach Food and Wine Festival...icially hit over 300 stores in South Florida since...ntly opened accounts include: CVS on Lincoln Road,... and,Chevron. Next Generation Waters offers indiv...
...gy Results Are In , , MUNDELEIN, Ill., Feb. 24 S...instrument manufacturer and laboratory information...atology instruments have been ranked best in indus...ed first in 21 (twenty-one) of the 30 (thirty) sur...
...ve the U.S. food supply is safer than it was a yea...f Minnesota,s Food Industry Center. , After Janua...nt of consumers in the study said they were confid...l in the most recent outbreak, which may have orig...
...se days, so people are paying close attention to h...lude eating at home more and canceling pricey gym ...d spending is out. But don,t allow tight times to ...ced Living magazine have published "31 Ways to St...
...global market research firm Synovate shows that le...accine during the past six months. Of those, only ... it at a retail clinic. , ...ed the flu vaccine during the past six months. Of ...
...ag filled with products as a gift with any $100 B...ORK, Feb. 24 Beauty.com, Inc., a wholly-owned sub..., announces Shoshanna Gruss as their Spring design...ll sized products is FREE with any $100 Beauty.com...
Other Medicine News:Health News:Next Generation Waters Successfully Reaches Over 300 Stores! 2Health News:Sysmex Customer Satisfaction Ranks Highest in Independent Market Research 2Health News:How to Stay Healthy on a Budget: 31 Money-saving Tips From Natural Solutions Magazine 2Health News:New survey: Flu Shot Still not Catching on, Especially at Retail Clinics 2Health News:NY Fashion Designer Shoshanna Creates Exclusive Spring Bag for Beauty.com 2Health News:NY Fashion Designer Shoshanna Creates Exclusive Spring Bag for Beauty.com 3
(Date:11/23/2009)...wswire/--LightSciencesOncology,Inc.(LSO)todayannou...lekta,toanewlycreatedseatonitsboardofdirectors.Mr....uctcompanies,includingElekta,tomarketleadership. ,...strengthinbusinessdevelopmenttotheboard,"saidLSO,s...eaderincancer-therapybusinessdevelopment.Hehasover...
(Date:11/23/2009)...RNewswire/--Sarnova,Inc.,thenation,sleadingspecial...icalservices(EMS)andrespiratorymarkets,announcedto...gementteam.ThenewexecutivesincludeTomDavid,executi...identandgeneralcounsel;SteveLacke,executivevicepre...residentofcorporatedevelopment. ,, "Ihaveworked...
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/--Anesiva,Inc.(Nasdaq: ...,PrichardhaveagreedtojointheAnesivaboardofdirector...ivaandArcionTherapeutics.Completionofthemergerissu...eviouslyannouncedAnesiva2009AnnualMeetingofStockho...sterPoint,Suite107A,SouthSanFrancisco,California,a...
Breaking Medicine Technology:Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Sarnova Expands Senior Management Team 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Revolutionizing the diagnosis of serious disease 47651 1Revolutionizing the diagnosis of serious disease 47651 2Study Results Show CAQH CORE Certification Dramatically Cuts Administrative Costs Accelerates I T Adoption by Providers and Health Plans 47648 1Study Results Show CAQH CORE Certification Dramatically Cuts Administrative Costs Accelerates I T Adoption by Providers and Health Plans 47648 2Study Results Show CAQH CORE Certification Dramatically Cuts Administrative Costs Accelerates I T Adoption by Providers and Health Plans 47648 3Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 1Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 2Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 3Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 4
...12 GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), ...pany, announced today that it has entered into a $...sion Capital Fund II, LLC, a Chicago-based,institu...million of its common stock to Fusion,Capital from...urities and,Exchange Commission has declared effec...
...., May 12 Arbios Systems, Inc.,(OTC Bulletin Boar...ived,approval from the U.S. Food and Drug Administ...ion ("IDE") to begin the pivotal clinical,trial fo...ody) liver assist,device for blood purification of... disease., "We are pleased to have received FDA a...
Other Medicine Technology:GeoVax Secures $10 Million Financing Commitment 2GeoVax Secures $10 Million Financing Commitment 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5
Buffered Wright-Giemsa Stain
Giemsa Stain
Albumin (BCP)
Albumin Reagent Set
Medicine Products: